HI SB 1633
died on adjournmentRELATING TO HEMP.
Hawaii · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did HI SB 1633 pass?
No. HI SB 1633 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-08): Carried over to 2026 Regular Session.
What is HI SB 1633 about?
Establishes a Green Building Tax Credit for costs related to the construction of a primary structure made with at least thirty per cent Hawaii-grown hemp material. Allows any hemp processor with a permit from the Department of Health to sell an edible or beverage cannabinoid product that contains a tetrahydrocannabinol concentration of not more than 2.5 milligrams per serving and not more than twenty-five servings per package. Prohibits the sale of an edible or beverage cannabinoid product to any person less than twenty-one years of age. Establishes child-resistant packaging requirements for edible cannabinoid products. Clarifies the tetrahydrocannabinol concentration limit for a non-edible legacy cannabinoid product or manufactured hemp product shall be subject only to federal restrictions. Amends the definition of "hemp biomass" to include stalks and foliage material. Requires the Department of Health to establish a dedicated hemp program to regulate hemp that is separate from the regulatory process for cannabinoid products with a high concentration of tetrahydrocannabinol. Effective 7/1/2050. (SD1)
Who sponsors HI SB 1633?
GABBARD, RICHARDS are the primary sponsors of HI SB 1633.
Description
Establishes a Green Building Tax Credit for costs related to the construction of a primary structure made with at least thirty per cent Hawaii-grown hemp material. Allows any hemp processor with a permit from the Department of Health to sell an edible or beverage cannabinoid product that contains a tetrahydrocannabinol concentration of not more than 2.5 milligrams per serving and not more than twenty-five servings per package. Prohibits the sale of an edible or beverage cannabinoid product to any person less than twenty-one years of age. Establishes child-resistant packaging requirements for edible cannabinoid products. Clarifies the tetrahydrocannabinol concentration limit for a non-edible legacy cannabinoid product or manufactured hemp product shall be subject only to federal restrictions. Amends the definition of "hemp biomass" to include stalks and foliage material. Requires the Department of Health to establish a dedicated hemp program to regulate hemp that is separate from the regulatory process for cannabinoid products with a high concentration of tetrahydrocannabinol. Effective 7/1/2050. (SD1)
- Introduced
- 2025-01-23
- Latest action
- 2025-12-08 — Carried over to 2026 Regular Session.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- GABBARDprimary
- RICHARDSprimary
Committees
Not provided by source.
Action timeline
Newest first
2025-12-08
Carried over to 2026 Regular Session.
carried-over
2025-02-14
Reported from AEN/HHS (Stand. Com. Rep. No. 647) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/WAM.
2025-02-14
Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/WAM.
passage,reading-2,referral-committee
2025-02-12
The committee(s) on AEN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in AEN were as follows: 5 Aye(s): Senator(s) Gabbard, Richards, DeCoite, Rhoads, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
committee-passage-favorable
2025-02-12
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.
committee-passage-favorable
2025-02-10
The committee(s) on AEN deferred the measure until 02-12-25 1:00PM; CR 224 & Videoconference.
deferral
2025-02-10
The committee(s) on HHS deferred the measure until 02-12-25 1:30PM; CR 225 & Videoconference.
deferral
2025-02-07
The committee(s) on AEN deferred the measure until 02-10-25 1:01PM; CR 224 & Videoconference.
deferral
2025-02-07
The committee(s) on HHS deferred the measure until 02-10-25 1:01PM; CR 225 & Videoconference.
deferral
2025-02-04
The committee(s) on AEN/HHS has scheduled a public hearing on 02-07-25 2:00PM; Conference Room 225 & Videoconference.
2025-01-27
Passed First Reading.
reading-1
2025-01-27
Referred to AEN/HHS, CPN/WAM.
referral-committee
2025-01-23
Introduced.
introduction
Versions
Documents
Votes
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS.
2025-02-12 · pass · 4-0
Member-level votes (5)
- San Buenaventura: yes
- Aquino: yes
- Hashimoto: yes
- Keohokalole: yes
- Fevella: not voting
The committee(s) on AEN recommend(s) that the measure be PASSED, WITH AMENDMENTS.
2025-02-12 · pass · 5-0
Member-level votes (5)
- Gabbard: yes
- Richards: yes
- DeCoite: yes
- Rhoads: yes
- Awa: yes
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=SB 1633. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.